Toksoplasmose%D8%AF%D8%A7%D8%A1_%D8%A7%D9%84%D9%85%D9%82%D9%88%D8%B3%D8%A7%D8%AA%D0%A2%D0%B0%D0%BA%D1%81%D0%B0%D0%BF%D0%BB%D0%B0%D0%B7%D0%BC%D0%BE%D0%B7Toxoplasmosi%D8%AA%D8%A7%DA%A9%D8%B3%DB%86%D9%BE%D9%84%D8%A7%D8%B3%D9%85%DB%86%D8%B3%DB%8C%D8%B3Category:ToxoplasmosisToxoplazm%C3%B3zaToxoplasmoseToxoplasmose%DE%93%DE%AE%DE%86%DE%B0%DE%90%DE%AF%DE%95%DE%B0%DE%8D%DE%A7%DE%92%DE%B0%DE%89%DE%AF%DE%90%DE%A8%DE%90%DE%B0%CE%A4%CE%BF%CE%BE%CE%BF%CF%80%CE%BB%CE%AC%CF%83%CE%BC%CF%89%CF%83%CE%B7ToxoplasmosisToxoplasmosisToksoplasmoosToxoplasmosi%D8%AA%D9%88%DA%A9%D8%B3%D9%88%D9%BE%D9%84%D8%A7%D8%B3%D9%85%D9%88%D8%B2ToksoplasmoosiToxoplasmoseTocsaplasm%C3%B3isToxoplasmose%D7%98%D7%95%D7%A7%D7%A1%D7%95%D7%A4%D7%9C%D7%96%D7%9E%D7%95%D7%96%D7%99%D7%A1ToksoplazmozaToxoplazm%C3%B3zis%D5%8F%D5%B8%D6%84%D5%BD%D5%B8%D5%BA%D5%AC%D5%A1%D5%A6%D5%B4%D5%B8%D5%A6ToksoplasmosisBogfrymlas%C3%B3ttToxoplasmosiToxoplasmosi%E3%83%88%E3%82%AD%E3%82%BD%E3%83%97%E3%83%A9%E3%82%BA%E3%83%9E%E7%97%87%D0%A2%D0%BE%D0%BA%D1%81%D0%BE%D0%BF%D0%BB%D0%B0%D0%B7%D0%BC%D0%BE%D0%B7%E1%9E%87%E1%9F%86%E1%9E%84%E1%9E%BA%E1%9E%8F%E1%9E%BB%E1%9E%80%E1%9E%9F%E1%9F%8A%E1%9E%B8%E1%9E%94%E1%9F%92%E1%9E%9B%E1%9E%B6%E1%9E%9F%E1%9F%92%E1%9E%98%E1%9E%BC%E1%9E%9F%E1%9F%8A%E1%9E%B8%E1%9E%9F%D0%A2%D0%BE%D0%BA%D1%81%D0%BE%D0%BF%D0%BB%D0%B0%D0%B7%D0%BC%D0%BE%D0%B7Toksoplazmoz%C4%97ToksoplasmosisToxoplasmoseToksoplasmose%E0%AC%9F%E0%AC%95%E0%AD%8D%E2%80%8C%E0%AC%B8%E0%AD%8B%E0%AC%AA%E0%AD%8D%E0%AC%B2%E0%AC%BE%E0%AC%9C%E0%AC%AE%E0%AD%8B%E0%AC%B8%E0%AC%BF%E0%AC%B8%E0%AD%8DToksoplazmozaToxoplasmoseToxoplasmoz%C4%83
about
Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular NeovascularizationInfluence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular ToxoplasmosisLatent Toxoplasmosis in Females With Borderline Personality DisorderPilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course SchizophreniaAntiretroviral Drug Interaction Study in Volunteers With HIVAssessment of Two Therapeutic Strategies in the Treatment of Children With Congenital ToxoplasmosisPrevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During PregnancyCerebral Toxoplasmosis and AIDSNew Diagnostic Approach for Congenital ToxoplasmosisPhase I Study of Pyrimethamine in Healthy Japanese and Caucasian SubjectsToxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of RelapseA Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-SulfadiazineA Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive PatientsA Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDSPhase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic EncephalitisPrimary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected PatientsA Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDSA Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii InfectionPyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital ToxoplasmosisPrevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART CentreImmunoblotting and Goldmann-Witmer Coefficient for Ocular ToxoplasmosisLyon Cohort of Maternal and Congenital Toxoplasma InfectionsDetermination of Genetic Susceptibility in Severe Recurrences of Ocular ToxoplasmosisEvaluation of Biological Biomarkers Diagnostic of Toxoplasmosis UveitisSpectral Optical Coherence Tomography Findings in Patients With Ocular ToxoplasmosisDexamethasone for Cerebral Toxoplasmosis
P1050
P1542
Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countriesIncreased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study.Zoonotic Chicken Toxoplasmosis in Some Egyptians GovernoratesPhagocyte responses to protozoan infection and how Toxoplasma gondii meets the challengeFeline toxoplasmosis in Finland: cross-sectional epidemiological study and case series studyNeglected parasitic infections in the United States: toxoplasmosisAcute Fatal Toxoplasmosis in Squirrels (Sciurus carolensis) with Bradyzoites in Visceral TissuesHigh Prevalence of Toxoplasmosis in Cats from Egypt: Isolation of Viable Toxoplasma gondii, Tissue Distribution, and Isolate DesignationWhy prevent, diagnose and treat congenital toxoplasmosis?Latent Toxoplasmosis gondii : Emerging Evidence for Influences on Neuropsychiatric DisordersDNA vaccination with a gene encoding Toxoplasma gondii Rhoptry Protein 17 induces partial protective immunity against lethal challenge in miceFatal Toxoplasma gondii infection in the giant pandaThe impact of lowering the cut-off value on the sensitivity of the Platelia Elisa IgG (Bio-Rad) test for toxoplasmosis diagnosisSeroprevalence of Toxoplasma gondii in wild boars, red deer and roe deer in PolandDetection of Toxoplasma gondii DNA in horse meat from supermarkets in France and performance evaluation of two serological testsRecombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c micePrenatal education for congenital toxoplasmosisCorticosteroids as adjuvant therapy for ocular toxoplasmosisPrenatal education for congenital toxoplasmosisPrenatal education for congenital toxoplasmosisCorticosteroids for ocular toxoplasmosisPrenatal education for congenital toxoplasmosisImmunoglobulin G avidity in diagnosis of toxoplasmic lymphadenopathy and ocular toxoplasmosisImmune response and immunopathology during toxoplasmosisAnti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in JapanToxoplasma gondii and schizophreniaEndochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosisSuccessful treatment of cerebral toxoplasmosis with cotrimoxazoleToxoplasmosis: A history of clinical observationsSources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital ToxoplasmosisSchizophrenia and toxoplasmosisClarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virusComparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probesPolyomyositis and myocarditis associated with acquired toxoplasmosis in an immunocompetent girlAssociation between congenital toxoplasmosis and parent-reported developmental outcomes, concerns, and impairments, in 3 year old childrenDeterminants of response to a parent questionnaire about development and behaviour in 3 year olds: European multicentre study of congenital toxoplasmosis.Detection of Toxoplasma gondii DNA by qPCR in the feces of a cat that recently ingested infected prey does not necessarily imply oocyst sheddingToxoplasmosis and anti-Toxoplasma effects of medicinal plant extracts-A mini-reviewPerformance of Polymerase Chain Reaction Analysis of the Amniotic Fluid of Pregnant Women for Diagnosis of Congenital Toxoplasmosis: A Systematic Review and Meta-AnalysisImpact of environmental factors on the emergence, transmission and distribution of Toxoplasma gondii
P921
Q61914404-7657DC24-E6B4-4F07-83BF-CCBBA7C3D204Q61967517-EFC8C613-22F1-4F57-8C65-299506359028Q64187102-2944868D-B6D4-44DB-9D0C-5D88B2A3B4E9Q64351047-4BA89F76-DC0C-4772-8F03-C65A5C5CFD47Q64647652-88D80FE3-EC42-49C3-8233-7E0056C2B805Q64653031-56F0F28B-B1B4-48C9-8A94-327A8B6B13B5Q64678408-E716921C-AA0A-401D-B963-95CED195FD6AQ64708838-77B54A24-4014-4387-8288-7065F37B381BQ64804793-422A7826-BB78-4E4E-9E7C-17E2A1245F2DQ64837080-38FB94A1-4547-4CFF-B41F-27B2226ADE9DQ66040501-B2580184-78FB-4D8C-ACB7-EE4C71E27A26Q66040572-014AE309-59B1-4CCF-9C3D-00664FDF7D22Q66040741-CAB726C7-3C1B-40FF-9AD6-E9CAD6DA4417Q66040748-299122F3-E98C-4573-82A5-241B3101F9E2Q66040925-F7E82967-96D5-46C7-BCE5-696143F63161Q66040928-BE8D4239-6F0B-4228-B5B0-AC98F7F64C45Q66041044-9012A861-9F51-49F2-855C-B420CB08732FQ66041052-FF2725E8-83FB-4B17-BBA1-A828B7E49488Q66062068-7FC9EA5A-2E34-4BC4-90F9-646341A10415Q66063747-A0AE11E9-D7D1-4013-A18B-7A28B733A78FQ66066677-28EC7705-59C6-4368-9015-9842395680DBQ66080070-958FFC95-8608-4333-A33D-7BC7BBCD3BF5Q66394377-AB6A4551-BC1F-4CE6-B6DB-9E28C65D7DC4Q66398200-D08DACCF-7B7C-4123-8335-F6A63F7D3F89Q83804514-FC94B72F-E662-4ADC-94C3-A03D0D615BD5Q90693194-6007DEB4-9F84-4B1D-B500-39A5624039F1
P1050
description
Infektionskrankheit
@de
Penyakit parasit pada manusia dan hewan berdarah panas
@id
enfermedad parasitaria ocasionada por el protozoo Toxoplasma gondii
@es
infekční onemocnění
@cs
maladie humaine
@fr
malattia parassitaria causata dal parassita Toxoplasma gondii.
@it
parasitic disease
@en
parasitic human disease
@en-gb
type parasittsjukdom
@nn
ziekte veroorzaakt door parasiet
@nl
name
Bogfrymlasótt
@is
Tocsaplasmóis
@ga
Toksoplasmoos
@et
Toksoplasmoosi
@fi
Toksoplasmose
@af
Toksoplasmosis
@ms
Toksoplazmoza
@hr
Toksoplazmozė
@lt
Toxoplasmose
@da
Toxoplasmose
@de
type
label
Bogfrymlasótt
@is
Tocsaplasmóis
@ga
Toksoplasmoos
@et
Toksoplasmoosi
@fi
Toksoplasmose
@af
Toksoplasmosis
@ms
Toksoplazmoza
@hr
Toksoplazmozė
@lt
Toxoplasmose
@da
Toxoplasmose
@de
altLabel
Haresyge
@da
Penyakit Toxoplasmosis
@ms
Toksoplasma
@fi
Toxoplasma gondii-infeksjon
@nn
Toxoplasmose
@nb
Toxoplasmosis
@ar
Toxoplasmosis
@ms
disseminated toxoplasmosis
@en
disseminated toxoplasmosis
@en-gb
nemoc šílených koťat
@cs
prefLabel
Bogfrymlasótt
@is
Tocsaplasmóis
@ga
Toksoplasmoos
@et
Toksoplasmoosi
@fi
Toksoplasmose
@af
Toksoplasmosis
@ms
Toksoplazmoza
@hr
Toksoplazmozė
@lt
Toxoplasmose
@da
Toxoplasmose
@de
P1692
P2176
P3827
P349
P486
P508
P646
P672
P1296
P1417
science/toxoplasmosis
P1461
toxoplasmosis